VENUS MEDTECH (HANGZHOU) INC. Funds and ETFs Venus Medtech (Hangzhou) Inc.
Equities
2500
CNE100003PJ8
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 HKD | -0.71% |
|
-.--% | -.--% |
| Apr. 01 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
| Mar. 28 | Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Venus Medtech (Hangzhou) Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.
Calendar
2024-08-28
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.157
CNY
Average target price
7.414
CNY
Spread / Average Target
+43.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 314M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 2500 Stock
- Funds and ETFs Venus Medtech (Hangzhou) Inc.
